$BLUE is slowly making progress again
CMS enters agreement with Vertex ($VRTX (-1,75 %) ), bluebird to improve access to gene therapies
$BLUE is slowly making progress again
CMS enters agreement with Vertex ($VRTX (-1,75 %) ), bluebird to improve access to gene therapies